Christoph Hagemeyer

Assoc Professor

  • 99 Commercial Road, Monash AMREP building Level 1, Walkway, via The Alfred Centre

    3004 Melbourne


Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Personal profile

Monash teaching commitment

HUP3011 - Human pathology: Atherosclerosis

HUP3011 - Human pathology: Vascular biology and disease

IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy

Central Clinical School Honours program "Molecular Imaging Technology"


Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.


Education/Academic qualification

Chemistry, PhD, University of Freiburg

Chemistry, MSc, University of Freiburg

External positions

NHMRC Senior Research Fellow, National Health & Medical Research Council (NHMRC)

1 Jan 201931 Dec 2023

A/Prof, RMIT University

1 Mar 2014 → …


  • PET CT
  • acute MI
  • animal models of human disease
  • antibodies
  • arterial thrombosis
  • drug delivery systems
  • microbubbles
  • molecular imaging
  • platelets
  • thrombosis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2023

Research Output 1999 2019

Functional Brush Poly(2-ethyl-2-oxazine)s: Synthesis by CROP and RAFT, Thermoresponsiveness and Grafting onto Iron Oxide Nanoparticles

Klein, T., Parkin, J., de Jongh, P. A. J. M., Esser, L., Sepehrizadeh, T., Zheng, G., De Veer, M., Alt, K., Hagemeyer, C. E., Haddleton, D. M., Davis, T. P., Thelakkat, M. & Kempe, K., May 2019, In : Macromolecular Rapid Communications. 40, 10, 6 p., 1800911.

Research output: Contribution to journalArticleResearchpeer-review

Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging

Bonnard, T., Jayapadman, A., Putri, J. A., Cui, J., Ju, Y., Carmichael, C., Angelovich, T. A., Cody, S. H., French, S., Pascaud, K., Pearce, H. A., Jagdale, S., Caruso, F. & Hagemeyer, C. E., 24 Jul 2018, In : ACS Nano. 12, 7, p. 6988-6996 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Magnetic fibrinolysis: putting the therapeutic wheels in a corkscrew motion

Medcalf, R. L., Hagemeyer, C. E. & Alt, K., 1 Apr 2018, In : Journal of Thrombosis and Haemostasis. 16, 4, p. 615-617 3 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis

Hanjaya-Putra, D., Haller, C., Wang, X., Dai, E., Lim, B., Liu, L., Jaminet, P., Yao, J., Searle, A., Bonnard, T., Hagemeyer, C. E., Peter, K. & Chaikof, E. L., 9 Aug 2018, In : JCI Insight. 3, 15, p. 1-18 18 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases

Chaudhary, R., Walder, K. R., Hagemeyer, C. E. & Kanwar, J. R., 1 Sep 2018, In : Current Atherosclerosis Reports. 20, 9, 10 p., 46.

Research output: Contribution to journalReview ArticleResearchpeer-review

Activities 2013 2014

  • 2 Editorial responsibility

Cardiovascular Therapeutics (Journal)

Christoph Hagemeyer (Associate editor)
2014 → …

Activity: Publication peer-review and editorial work typesEditorial responsibility

PLoS ONE (Journal)

Christoph Hagemeyer (Associate editor)
2013 → …

Activity: Publication peer-review and editorial work typesEditorial responsibility